Vaxdyn Readies Vaccines To Target AMR Bacteria

First Spanish Biotech To Get CARB-X Funding

 
• By Sten Stovall
  
Vaxdyn
Researcher-founded Vaxdyn targets infections caused by highly antibiotic resistant bacteria. • Source: Vaxdyn

More from Emerging Company Profiles

More from Start-Ups & SMEs